Therapeutic potential of LINS01 histamine H3 receptor antagonists as antineoplastic agents for triple negative breast cancer.
Ospital IA, Táquez Delgado MA, Nicoud MB, Corrêa MF, Borges Fernandes GA, Andrade IW, Lauretta P, Martínez Vivot R, Comba MB, Zanardi MM, Speisky D, Uriburu JL, Fernandes JPS, Medina VA.
Ospital IA, et al. Among authors: fernandes jps.
Biomed Pharmacother. 2024 May;174:116527. doi: 10.1016/j.biopha.2024.116527. Epub 2024 Apr 4.
Biomed Pharmacother. 2024.
PMID: 38579399
Free article.